Longevity & AgingResearch PaperPaywall

Fat Tissue Actively Drives Wound Healing and Scar Formation

Stanford researchers reveal white adipose tissue plays a dynamic, active role in wound healing — not just energy storage.

Sunday, June 14, 2026 2 views
Published in Adv Wound Care (New Rochelle)
Cross-section microscopy of skin layers showing glowing adipocyte cells surrounding a healing wound, soft golden light on fat tissue.

Summary

A Stanford review challenges the long-held view that fat tissue is a passive player in wound repair. White adipose tissue (WAT), including dermal and subcutaneous fat, actively regulates inflammation, cell proliferation, and tissue remodeling during healing. Adipocytes communicate through signaling pathways that influence fibroblasts and immune cells at every stage of wound healing. Notably, multiple fibrotic conditions — where scarring replaces healthy tissue — are associated with reduced adipose tissue. The review also highlights emerging therapeutic uses of WAT and its derivatives to improve healing outcomes. Understanding how adipocyte subpopulations behave during repair could unlock new strategies for treating chronic wounds, surgical scars, and fibrotic diseases.

Detailed Summary

For decades, white adipose tissue (WAT) was regarded primarily as a passive energy reservoir and thermal insulator. A comprehensive review from Stanford University's Division of Plastic and Reconstructive Surgery now argues that this view fundamentally underestimates fat tissue's role in skin repair and scarring.

The review focuses specifically on dermal and subcutaneous WAT — the fat layers closest to the skin — and their participation across all three classical phases of wound healing: inflammation, proliferation, and remodeling. While prior research has extensively mapped the contributions of immune cells and fibroblasts to wound biology, adipocytes have received comparatively little attention in this context.

Key findings presented suggest that adipocyte subpopulations actively regulate healing through distinct signaling pathways. The interplay between fat cells and other wound-healing players, such as macrophages and myofibroblasts, appears to influence whether tissue regenerates cleanly or develops fibrosis. Critically, fibrotic conditions across multiple organ systems are consistently associated with a depletion of local adipose tissue, implying that fat loss may drive pathological scarring.

The review also surveys therapeutic applications of WAT and its derivatives — including fat grafting and adipose-derived stem cells — as strategies to enhance wound repair and reduce fibrosis. These approaches are already in clinical use but could be refined with a deeper mechanistic understanding of adipocyte biology.

As a review paper based on existing literature rather than original experimental data, the conclusions are synthesized from heterogeneous studies with varying models and methodologies. Nonetheless, this work provides a timely framework for repositioning adipose tissue as a central therapeutic target in wound care and regenerative medicine.

Key Findings

  • Dermal and subcutaneous white adipose tissue actively regulates all three phases of wound healing.
  • Adipocytes engage in critical signaling crosstalk with immune cells and fibroblasts during repair.
  • Fibrotic conditions across multiple tissues are consistently linked to local adipose tissue depletion.
  • WAT derivatives, including adipose-derived stem cells, show therapeutic promise for improved wound outcomes.
  • Adipocyte subpopulations may be modulated to shift wound healing from fibrosis toward regeneration.

Methodology

This is a narrative review article from Stanford University synthesizing current literature on adipose tissue biology in wound healing. No original experimental data were generated; findings are drawn from existing in vitro, animal, and clinical studies. The review covers mechanistic pathways and therapeutic applications across the inflammation, proliferation, and remodeling phases of wound repair.

Study Limitations

As a review, this paper does not present new experimental data, limiting causal conclusions. The field lacks large-scale human clinical trials specifically examining adipocyte-targeted wound therapies. Heterogeneity across the cited studies — in terms of models, wound types, and adipose tissue compartments — may affect the generalizability of synthesized conclusions.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.